National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

clarithromycin
A semisynthetic 14-membered ring macrolide antibiotic. Clarithromycin binds to the 50S ribosomal subunit and inhibits RNA-dependent protein synthesis in susceptible organisms. Clarithromycin has been shown to eradicate gastric MALT (mucosa-associated lymphoid tissue) lymphomas, presumably due to the eradication of tumorigenic Helicobacter pylori infection. This agent also acts as a biological response modulator, possibly inhibiting angiogenesis and tumor growth through alterations in growth factor expression. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Abbott-56268
US brand name:Biaxin
Abbreviation:CLARITH
Chemical structure name:6-O-Methylerythromycin



Previous:Citroma, cladribine, Clafen, Claforan, Claravis
Next:Class 1 PI3K kinase family inhibitor XL147, class III receptor tyrosine kinase inhibitor AC220, clindamycin/hydrocortisone lotion, Clino-San vaginal lubricant, Clinoril

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov